Detailansicht

Wissensnetz

Person

Iris Divé (1986-)

Name	Iris Divé
Zeit	1986- (Lebensdaten)
Ort	Frankfurt am Main (Geburtsort) Deutschland
Geschlecht	weiblich
Variante	Iris Elisabeth Beate Divé
Beziehung	Medizin (Studienfach)
Weitere Angaben	Diss. Medizinische Fakultät der Univ. Freiburg (Breisgau)
Datensatztyp	Person
GND-Nummer	1050912217
Datensatz-ID	1050912217
Beteiligt an alle anzeigen Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy Local anesthetic-induced central nervous system toxicity during interscalene brachial plexus block: a case series study of three patients Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment Die Effekte von CNTF und LIF auf Proliferation und Differenzierung der humanen neuralen Stammzelllinie HNSC.100

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Iris Divé (1986-)

Molecular matched targeted therapies for primary brain tumors - a single center retrospective analysis

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy

Local anesthetic-induced central nervous system toxicity during interscalene brachial plexus block: a case series study of three patients

Activation of epidermal growth factor receptor sensitizes glioblastoma cells to hypoxia-induced cell death

Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients

Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment

Die Effekte von CNTF und LIF auf Proliferation und Differenzierung der humanen neuralen Stammzelllinie HNSC.100